These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 9293460

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of growth factors in the formation of blood vessels.
    Risau W, Zerwes HG.
    Z Kardiol; 1989; 78 Suppl 6():9-11. PubMed ID: 2482588
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Angiotensin and its mediators. Their pathogenic and clinical significance in "angiogenic diseases"].
    Szekanecz Z, Bordán E, Szabó Z, Szegedi G.
    Orv Hetil; 1998 Feb 01; 139(5):227-34. PubMed ID: 9489376
    [Abstract] [Full Text] [Related]

  • 7. Continuous and discrete mathematical models of tumor-induced angiogenesis.
    Anderson AR, Chaplain MA.
    Bull Math Biol; 1998 Sep 01; 60(5):857-99. PubMed ID: 9739618
    [Abstract] [Full Text] [Related]

  • 8. [Angiogenesis and its regulation].
    Iwaguchi T.
    Gan To Kagaku Ryoho; 1993 Jan 01; 20(1):1-9. PubMed ID: 7678486
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B.
    Am J Pathol; 1998 Jun 01; 152(6):1433-43. PubMed ID: 9626048
    [Abstract] [Full Text] [Related]

  • 12. [Does oncogene c-ets 1 participate in the regulation of tumor angiogenesis?].
    Vandenbunder B, Wernert N, Stehelin D.
    Bull Cancer; 1993 Jan 01; 80(1):38-49. PubMed ID: 7515728
    [Abstract] [Full Text] [Related]

  • 13. Pro-angiogenic cytokines and their role in tumor angiogenesis.
    Neufeld G, Kessler O.
    Cancer Metastasis Rev; 2006 Sep 01; 25(3):373-85. PubMed ID: 17006765
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The interaction of HGF-SF with other cytokines in tumor invasion and angiogenesis.
    Rosen EM, Zitnik RJ, Elias JA, Bhargava MM, Wines J, Goldberg ID.
    EXS; 1993 Sep 01; 65():301-10. PubMed ID: 7678533
    [Abstract] [Full Text] [Related]

  • 16. [The role of matrix metalloproteinases and their tissue inhibitors in angiogenesis].
    Bogaczewicz J, Dudek W, Zubilewicz T, Wroński J, Przywara S, Chodorowska G, Krasowska D.
    Pol Merkur Lekarski; 2006 Jul 01; 21(121):80-5. PubMed ID: 17007300
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?].
    Joussen AM, Kirchhof B, Gottstein C.
    Ophthalmologe; 2003 Apr 01; 100(4):284-91. PubMed ID: 12682760
    [Abstract] [Full Text] [Related]

  • 19. The 9E3/CEF4 gene product is a chemotactic and angiogenic factor that can initiate the wound-healing cascade in vivo.
    Martins-Green M, Feugate JE.
    Cytokine; 1998 Jul 01; 10(7):522-35. PubMed ID: 9702416
    [Abstract] [Full Text] [Related]

  • 20. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies.
    McDougall SR, Anderson AR, Chaplain MA.
    J Theor Biol; 2006 Aug 07; 241(3):564-89. PubMed ID: 16487543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.